Generate a tailored SOP for Dr. Katherine Sprugel. Improve your application with a focused, well-structured draft.
Katherine Sprugel has over 25 years of experience in preclinical research and development within the biotechnology industry, having worked for companies such as ZymoGenetics, PathoGenesis, and Chiron. Currently, she serves as the Scientific Director in Toxicology Sciences at Amgen in Seattle, where she focuses on safety assessments and nonclinical development strategies for drugs in the fields of inflammation and oncology. Her academic background includes a PhD from Michigan State University and a BS from the University of the Pacific. In her role, Sprugel emphasizes the importance of mentorship and is available to guide new students, particularly in the realms of regulatory toxicology and science communication. Her research interests encompass protein pharmacology, including the identification and testing of the therapeutic potential of novel proteins, as well as biotherapeutic drug development amid the evolving regulatory landscape for biologics and inhalation toxicology.
Standard Graduate School requirements for University of Washington apply to most departments listed unless specified otherwise by the program.